Recombinant human granulocyte-macrophage colony stimulating factor (rhGM-CSF) reduces infection-related mortality after allogeneic T-cell depleted BMT.
De Witte
T
T
University Hospital Nijmegen, The Netherlands.
Gratwohl
A
A
Van der Lely
N
N
Bacigalupo
A
A
Stern
A C
AC
Speck
B
B
Schattenberg
A
A
Nissen
C
C
Gluckman
E
E
Fibbe
W E
WE
D016026:Bone Marrow Transplantation / Q000009:adverse effects*; D004311:Double-Blind Method; D005060:Europe / Q000453:epidemiology; D006085:Graft Survival / Q000187:drug effects; D016178:Granulocyte-Macrophage Colony-Stimulating Factor / Q000494:pharmacology / Q000627:therapeutic use*; D006410:Hematopoiesis / Q000187:drug effects; D006801:Humans; D007155:Immunologic Factors / Q000494:pharmacology / Q000627:therapeutic use*; D017053:Infection Control; D007239:Infections / Q000209:etiology / Q000401:mortality; D007958:Leukocyte Count / Q000187:drug effects; D008212:Lymphocyte Depletion; D009503:Neutropenia / Q000150:complications / Q000628:therapy; D011446:Prospective Studies; D011994:Recombinant Proteins / Q000494:pharmacology / Q000627:therapeutic use; D013601:T-Lymphocytes / Q000276:immunology
D007155:Immunologic Factors; D011994:Recombinant Proteins; D016178:Granulocyte-Macrophage Colony-Stimulating Factor